Cargando…
Isoalantolactone Enhances the Antitumor Activity of Doxorubicin by Inducing Reactive Oxygen Species and DNA Damage
Colon cancer is one of the most common cancer in the world. Doxorubicin (DOX) is a classical anti-tumor drug which widely used in treatment of cancers, however, high toxicity limited its further clinical application. Thus, it is urgent to find new drugs with low toxicity and high efficiency to treat...
Autores principales: | Wu, Fengjiao, Shao, Rongrong, Zheng, Peisen, Zhang, Tingting, Qiu, Chenyu, Sui, Hehuan, Li, Shaotang, Jin, Libo, Pan, Huanle, Jin, Xiance, Zou, Peng, Cui, Ri, Xie, Congying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8821528/ https://www.ncbi.nlm.nih.gov/pubmed/35145916 http://dx.doi.org/10.3389/fonc.2022.813854 |
Ejemplares similares
-
Reactive Oxygen Species Mediate Isoalantolactone-Induced Apoptosis in Human Prostate Cancer Cells
por: Rasul, Azhar, et al.
Publicado: (2013) -
Isoalantolactone Induces Reactive Oxygen Species Mediated Apoptosis in Pancreatic Carcinoma PANC-1 Cells
por: Khan, Muhammad, et al.
Publicado: (2012) -
Targeting Apoptosis Pathways in Cancer with Alantolactone and Isoalantolactone
por: Rasul, Azhar, et al.
Publicado: (2013) -
Microwave-assisted Extraction of Alantolactone and Isoalantolactone from Inula helenium
por: Zhao, Y. M., et al.
Publicado: (2015) -
Ultrasound-assisted extraction of alantolactone and isoalantolactone from Inula helenium roots
por: Trendafilova, Antoaneta, et al.
Publicado: (2010)